Not applicableStudy completedNCT03295071What this trial is testingREALITY LHON RegistryWho this might be right forLeber Hereditary Optic Neuropathy GenSight Biologics 44
Testing effectiveness (Phase 2)Study completedNCT04621136What this trial is testingPhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of PrematurityWho this might be right forRetinopathy of Prematurity Kyushu University 24
Early research (Phase 1)Study completedNCT00002016What this trial is testingA Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV RetinitisWho this might be right forCytomegalovirus RetinitisHIV Infections Sandoz
Testing effectiveness (Phase 2)Active Not RecruitingNCT05152914What this trial is testingIntravitreal ERT to Prevent Retinal Disease Progression in Children With CLN2Who this might be right forNeuronal Ceroid Lipofuscinosis Type 2 David L Rogers, MD 5
Large-scale testing (Phase 3)Looking for participantsNCT06067958What this trial is testingIntranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of PrematurityWho this might be right forRetinopathy of PrematurityDexmedetomidine Assaf-Harofeh Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT03073733What this trial is testingSafety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis PigmentosaWho this might be right forRetinitis Pigmentosa jCyte, Inc 84
Not applicableEnded earlyNCT02257307What this trial is testingTelemedicine Approaches to Evaluating Acute-Phase ROP eROP Implementation ProjectWho this might be right forRetinopathy of Prematurity Children's Hospital of Philadelphia 244
Testing effectiveness (Phase 2)Ended earlyNCT01367444What this trial is testingPhase I/IIA Study of SAR422459 in Participants With Stargardt's Macular DegenerationWho this might be right forStargardt's Disease Sanofi 27
Testing effectiveness (Phase 2)Looking for participantsNCT06628947What this trial is testingA Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis PigmentosaWho this might be right forRetinitis Pigmentosa Kiora Pharmaceuticals, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT02255032What this trial is testingSuprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious UveitisWho this might be right forUveitisMacular EdemaUveitis, Posterior+3 more Clearside Biomedical, Inc. 22
Not applicableStudy completedNCT01097564What this trial is testingCOL4A1 Gene Related Cerebra-retinal AngiopathyWho this might be right forCerebra-retinal Angiopathy Assistance Publique - Hôpitaux de Paris 132
Testing effectiveness (Phase 2)Study completedNCT00664599What this trial is testingRituximab for the Treatment of Severe Ocular Manifestations of Behcet's DiseaseWho this might be right forBehcet's Syndrome Tehran University of Medical Sciences 20
Testing effectiveness (Phase 2)Study completedNCT04604899What this trial is testingSafety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis PigmentosaWho this might be right forRetinitis Pigmentosa jCyte, Inc 30
Not applicableLooking for participantsNCT06491615What this trial is testingNational Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic DiseasesWho this might be right forInherited Ophthalmic DiseasesHypopigmentation DisorderCorneal Dystrophy+4 more National Eye Institute (NEI) 1,000
Not applicableEnrolling By InvitationNCT05921162What this trial is testingA Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal InjectionWho this might be right forRetinitis PigmentosaRetinal DiseaseRetinal Degeneration Nanoscope Therapeutics Inc. 11
Not applicableWithdrawnNCT05045703What this trial is testingThe Dark-Adapted Retinal Function Response in Choroideremia (DARC) StudyWho this might be right forChoroideremia Duke University
Not applicableStudy completedNCT03865134What this trial is testingEvaluation of Visual - Motor Development in Children With Retinopathy of PrematurityWho this might be right forPremature RetinopathyVisual ImpairmentMotor Delay Istanbul Medipol University Hospital 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT02402660What this trial is testingPhase 2 Tolerability and Effects of ALK-001 on Stargardt DiseaseWho this might be right forStargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy+1 more Alkeus Pharmaceuticals, Inc. 160
Large-scale testing (Phase 3)Ended earlyNCT01987596What this trial is testingStudy of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With CancerWho this might be right forChildhood Choroid Plexus TumorChildhood MedulloblastomaChildhood Pineoblastoma+8 more Barbara Ann Karmanos Cancer Institute 23
Early research (Phase 1)Ended earlyNCT00702819What this trial is testingPan-VEGF Blockade for the Treatment of Retinopathy of PrematurityWho this might be right forRetinopathy of Prematurity Vision Research Foundation 2